1. Home
  2. MXE vs COCH Comparison

MXE vs COCH Comparison

Compare MXE & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Equity and Income Fund Inc. (The)

MXE

Mexico Equity and Income Fund Inc. (The)

N/A

Current Price

$12.98

Market Cap

55.7M

Sector

Finance

ML Signal

N/A

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

N/A

Current Price

$7.19

Market Cap

51.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MXE
COCH
Founded
1990
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Blank Checks
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
55.7M
51.3M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
MXE
COCH
Price
$12.98
$7.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $21.67
AVG Volume (30 Days)
2.7K
★ 20.3K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 2.66%
N/A
EPS Growth
N/A
★ 17.45
EPS
★ N/A
N/A
Revenue
N/A
★ $241,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.14
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.11
52 Week Low
$11.57
$4.72
52 Week High
$14.30
$47.70

Technical Indicators

Market Signals
Indicator
MXE
COCH
Relative Strength Index (RSI) 55.77 18.22
Support Level $12.79 $4.72
Resistance Level $13.55 $36.51
Average True Range (ATR) 0.27 0.67
MACD 0.06 0.86
Stochastic Oscillator 70.59 88.32

Price Performance

Historical Comparison
MXE
COCH

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek high total return through capital appreciation and current income. It invests in equity securities, convertible securities and debt securities and may also invest in other securities such as capital development certificates, real estate investment trusts, mutual funds, exchange traded funds, preferred stocks, rights and warrants.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: